By Bernadette Toner
Recent comments from a Medicare official indicate the Centers for Medicare & Medicaid Services has no plans to consider reimbursement for whole-genome sequencing-based tests any time soon.
Molina Healthcare, Paramount Healthcare, and Providence Health Plans join a growing list of health plans that are using McKesson's services to determine the appropriateness of molecular and genetic testing for individual patients.
The decision means that "Aetna has decided to pay for AlloMap as a matter of policy," an XDx spokesperson said. Prior to the policy decision, "Aetna would require medical justification for each test to consider whether or not to pay" for it.